{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:05:19Z","timestamp":1790096719231,"version":"4.0.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Inborn Errors of Immunity (IEI) are heterogeneous disorders of immunity with variable clinical presentation and outcome. This is the first comprehensive report from the United Arab Emirates aiming to describe the demographics, clinical characteristics, categories, treatment modalities and outcome of patients with IEI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study was conducted on patients who attended Tawam Hospital between 2016-2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 162 patients with IEI, of whom 152 were children. The age of onset of symptoms ranged between birth to 38 years. About two-thirds of patients were Emirati nationals, 64.2% had consanguineous parents and 38.3% of cases were familial. Patients were classified as; immunodeficiencies affecting cellular and humoral immunity (20.4%), combined immunodeficiencies with associated or syndromic features (38.3%), predominantly antibody deficiencies (16%), immune dysregulation (4.3%), congenital defects of phagocytes number or function (8.6%), defects in intrinsic and innate immunity (1.9%) autoinflammatory disorders (1.9%), complement deficiency (6.2%), bone marrow failure (1.9%) and phenocopies of inborn errors of immunity (0.6%). Genetic testing was performed in 85.2% of patients with a diagnostic yield of 92.7%. Complications included bronchiectasis, neoplasia, and vaccine-related infections. Immunoglobulin therapy and antimicrobial prophylaxis were both used in (51.9%) of patients while (20.4%) underwent hematopoietic stem cell transplantation (HSCT). The overall mortality rate was 10.5%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This report highlights the burden of IEI in the UAE. Ongoing education of physicians, establishment of a national registry and considering changes to early BCG vaccination are measures recommended to improve outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2022.837243","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T23:38:32Z","timestamp":1643585912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["The Spectrum of Inborn Errors of Immunity in the United Arab Emirates: 5 Year Experience in a Tertiary Center"],"prefix":"10.3389","volume":"13","author":[{"given":"Hiba Mohammed","family":"Shendi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna Ali","family":"Al Kuwaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Darwaish","family":"Al Dhaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleiman","family":"Al-Hammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human Inborn Errors of Immunity: 2019 Update on the Classification From the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-00980-1","article-title":"The Ever-Increasing Array of Novel Inborn Errors of Immunity: An Interim Update by the IUIS Committee","volume":"41","author":"Tangye","year":"2021","journal-title":"J Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","article-title":"Primary Immunodeficiency Diseases Worldwide: More Common Than Generally Thought","volume":"33","author":"Bousfiha","year":"2013","journal-title":"J Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00316","article-title":"Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies","volume":"10","author":"Cifaldi","year":"2019","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.05.042","article-title":"Primary Immunodeficiency Diseases: Genomic Approaches Delineate Heterogeneous Mendelian Disorders","volume":"139","author":"Stray-Pedersen","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.02.040","article-title":"Clinical Application of Whole-Genome Sequencing in Patients With Primary Immunodeficiency","volume":"136","author":"Mousallem","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0102-8","article-title":"Prevalence and Morbidity of Primary Immunodeficiency Diseases, United States 2001-2007","volume":"34","author":"Kobrynski","year":"2014","journal-title":"J Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00678","article-title":"Primary Immunodeficiency Diseases in Highly Consanguineous Populations From Middle East and North Africa: Epidemiology, Diagnosis, and Care","volume":"8","author":"Al-Mousa","year":"2017","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01053-z","article-title":"Consensus Middle East and North Africa Registry on Inborn Errors of Immunity","volume":"41","author":"Aghamohammadi","year":"2021","journal-title":"J Clin Immunol"},{"key":"B11","unstructured":""},{"key":"B12","unstructured":"Working Definitions for Clinical Diagnosis of PID"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1017\/s0021932097004914","article-title":"Consanguineous Marriages in the United Arab Emirates","volume":"29","author":"Al-Gazali","year":"1997","journal-title":"J Biosoc Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01754","article-title":"The Kuwait National Primary Immunodeficiency Registry 2004-2018","volume":"10","author":"Al-Herz","year":"2019","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0337-7","article-title":"Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital","volume":"36","author":"Al-Tamemi","year":"2016","journal-title":"J Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13125","article-title":"The United Kingdom Primary Immune Deficiency (UKPID) Registry 2012 to 2017","volume":"192","author":"Shillitoe","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01272","article-title":"The German National Registry of Primary Immunodeficiencies (2012-2017)","volume":"10","author":"El-Helou","year":"2019","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-5-393","article-title":"Attentiveness of Pediatricians to Primary Immunodeficiency Disorders","volume":"5","author":"Al-Hammadi","year":"2012","journal-title":"BMC Res Notes"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15071","DOI":"10.1038\/nrdp.2015.71","article-title":"22q11.2 Deletion Syndrome","volume":"1","author":"McDonald-McGinn","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00844-0","article-title":"The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019)","volume":"40","author":"Lougaris","year":"2020","journal-title":"J Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13104-017-2499-7","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) Infections in Infants With Immunodeficiency","volume":"10","author":"Al-Hammadi","year":"2017","journal-title":"BMC Res Notes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpam.2015.05.004","article-title":"BCG Related Complications: A Single Center, Prospective Observational Study","volume":"2","author":"Alfawaz","year":"2015","journal-title":"Int J Pediatr Adolesc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5144\/0256-4947.2021.24","article-title":"Bacillus Calmette-Gu\u00e9rin Vaccine-Related Complications in Children in Oman","volume":"41","author":"Al Waili","year":"2021","journal-title":"Ann Saudi Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.01.038","article-title":"Primary Immunodeficiency Diseases and Bacillus Calmette-Gu\u00e9rin (BCG)-Vaccine-Derived Complications: A Systematic Review","volume":"8","author":"Fekrvand","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9812-y","article-title":"Primary Immunodeficiency Diseases in Children: 15 Year Experience in a Tertiary Care Medical Center in Qatar","volume":"33","author":"Ehlayel","year":"2013","journal-title":"J Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.837243\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T23:38:36Z","timestamp":1643585916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.837243\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2022.837243"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.837243","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"article-number":"837243"}}